Jackman DM , Johnson BE . Small-cell lung cancer .Phase Ⅱ trial of two dose levels of temsirolimus ( CCI-779 ) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy : a trial of the East ......